Baseline and changes in inflammatory parameters for patients with EGFR ‐mutated NSCLC treated with afatinib
Sign Up to like & getrecommendations! Published in 2025 at "Thoracic Cancer"
DOI: 10.1111/1759-7714.15338
Abstract: This study investigated the relationship between inflammatory biomarkers (lymphocyte ratio [NLR], monocyte‐to‐lymphocyte ratio [MLR], and platelet‐to‐lymphocyte ratio [PLR]) and the treatment outcomes of patients with non‐small cell lung cancer (NSCLC) treated with afatinib. read more here.
Keywords: inflammatory parameters; treated afatinib; baseline changes; changes inflammatory ... See more keywords